KeraLink International helped ensure universal access to treatment for corneal blindness in theUnited States.  With your help, we were able to eliminate waiting lists for corneal transplants and effectively cure corneal blindness.  Today, we are working to eradicate corneal blindness globally and will need your help even more.  Most of the world’s corneal blind are young and live in low- and middle-income countries (LMICs).  In LMICs, access to corneal transplants is limited.  So, we are researching and developing new technologies to help prevent, diagnose, treat, and cure the corneal conditions that lead to blindness and investing in corneal regeneration technologies to treat the cornea without human tissue transplantation. With your help, we can ensure all these technologies are brought to market universally and affordably in LMICs.